Glucovance, a new tablet that combines glyburide and metformin

Bristol-Myers Squibb is now marketing Glucovance, a new tablet that combines glyburide and metformin.

Many patients get metformin and a sulfonylurea for diabetes. These drugs have additive effects to lower blood sugar.

The combination can lower HbA1c by 1.5% to 3.5%...depending on the patient's initial HbA1c.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote